- Home
- NL vs SLN Comparison
NL vs SLN Comparison
Compare NL & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NL
- SLN
- Stock Information
- Founded
- NL 1891
- SLN 1994
- Country
- NL United States
- SLN United Kingdom
- Employees
- NL N/A
- SLN N/A
- Industry
- NL Major Chemicals
- SLN Biotechnology: Pharmaceutical Preparations
- Sector
- NL Industrials
- SLN Health Care
- Exchange
- NL Nasdaq
- SLN Nasdaq
- Market Cap
- NL 320.5M
- SLN 299.4M
- IPO Year
- NL N/A
- SLN N/A
- Fundamental
- Price
- NL $6.52
- SLN $4.81
- Analyst Decision
- NL Sell
- SLN Buy
- Analyst Count
- NL 1
- SLN 5
- Target Price
- NL $6.00
- SLN $32.60
- AVG Volume (30 Days)
- NL 27.5K
- SLN 61.8K
- Earning Date
- NL 08-06-2025
- SLN 08-07-2025
- Dividend Yield
- NL 5.50%
- SLN N/A
- EPS Growth
- NL 141.37
- SLN N/A
- EPS
- NL 1.10
- SLN N/A
- Revenue
- NL $152,721,000.00
- SLN $27,169,000.00
- Revenue This Year
- NL $15.75
- SLN N/A
- Revenue Next Year
- NL $2.44
- SLN N/A
- P/E Ratio
- NL $5.96
- SLN N/A
- Revenue Growth
- NL N/A
- SLN 22.28
- 52 Week Low
- NL $5.29
- SLN $1.97
- 52 Week High
- NL $9.42
- SLN $20.48
- Technical
- Relative Strength Index (RSI)
- NL 51.90
- SLN 34.88
- Support Level
- NL $6.30
- SLN $4.91
- Resistance Level
- NL $6.82
- SLN $5.34
- Average True Range (ATR)
- NL 0.33
- SLN 0.48
- MACD
- NL 0.04
- SLN -0.05
- Stochastic Oscillator
- NL 60.00
- SLN 0.71
About NL NL Industries Inc.
NL Industries Inc is a holding company that operates in the component products industry. Through its subsidiary, it manufactures engineered components that are sold to a range of industries, including recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare, gas stations and vending equipment. It also produces a precision ball bearing slide, security products, and ergonomic computer support systems. The company derives majority of its revenue from Europe.
About SLN Silence Therapeutics Plc American Depository Share
Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.